SmPC - Dipyridamole Tablets BP 25mg: Change history
View Summary of Product Characteristics (SmPC - Dipyridamole Tablets BP 25mg)
Last updated on this site: 23 Sep 2025
To add ATC code (B01AC07) and pharmacotherapeutic group in line with the WHO ATC Index. Consequently section 5.1 of the SPC has been indexed.
Approval date: 19/09/2025
SmPC sections updated: 5.1 and 10
Last updated on this site: 23 Sep 2025
To add ATC code (B01AC07) and pharmacotherapeutic group in line with the WHO ATC Index. Consequently section 5.1 of the SPC has been indexed.
Approval date: 19/09/2025
SmPC sections updated: 5.1 and 10
-
Changes: (Updated: 23 Sep 2025)
To add ATC code (B01AC07) and pharmacotherapeutic group in line with the WHO ATC Index. Consequently section 5.1 of the SPC has been indexed.
Approval date: 19/09/2025
SmPC sections updated: 5.1 and 10
-
Changes: (Updated: 03 Feb 2023)
Variation Description: SmPC sections 2, 4.4 and 4.8 have been updated to amend side-effect frequencies in line with the recommendation from the MHRA after approval of variation ref PL 00142/0308 - 0060 and to include the Excipients of known effect section. Consequentially, the cartons and PIL have also been updated to correct the excipient declarations in line with current QRD template.
SmPC sections updated – 2, 4.4, 4.8 and 10.
-
Changes: (Updated: 20 Sep 2022)
Initial upload